Recombinant prostate specific antigen: Began Phase I/II trial in five patients who have failed hormonal therapy

Jenner Technologies, Danville, Calif. Product: Recombinant prostate specific antigen (PSA) vaccine and an adjuvant, delivered by a liposome carrier that targets the reticuloendothelial system Indicati...